Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

Also called NCT01173094

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01173094
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01173094. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)
Acronym
DCLI-II
Condition
Vascular Diseases
Condition
Diabetes
Intervention (Device)
Percutaneous Transluminal Angioplasty
Intervention (Device)
below-knee arterial bypass
Lead sponsor
Peking Union Medical College Hospital (class: other)
Collaborator
Beijing Tongren Hospital (class: other)
Collaborator
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct01173094
Content hash
4a292abf33ca1cbf2050eac84d07051d6cab0e032adcf343958b23b1d675b52d